Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charité LMD registry - Scorecard - MDSpire
Advertisement
Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charité LMD registry
Clinical Scorecard: Clinical Features and Outcomes of Leptomeningeal Disease With and Without Accompanying Brain Metastases: Findings from an Exploratory Analysis of the Charité LMD Database
At a Glance
Category
Detail
Condition
Leptomeningeal disease (LMD), also known as leptomeningeal metastasis (LMM), involving spread of cancer cells into leptomeninges and/or cerebrospinal fluid
Key Mechanisms
Cancer cell dissemination into leptomeninges and CSF, often late-stage complication of metastatic malignancies with neurological deficits and hydrocephalus
Target Population
Patients with solid tumor malignancies (breast cancer, NSCLC, melanoma, gastrointestinal tumors) with LMD, with or without brain metastases
Care Setting
Tertiary care center managing metastatic CNS disease with multidisciplinary approaches including neurosurgery, radiotherapy, and systemic therapies
Key Highlights
LMD occurs in 2–12% of metastatic cancer cases and up to 37% of patients with brain metastases at later disease stages
Diagnosis involves cranial/spinal MRI, CSF cytology, and biopsy in unclear cases; classification includes classic linear and nodular LMD
Prognostic factors include tumor type, Karnofsky performance score, CSF cytology positivity, LMD pattern, targeted therapies, and primary tumor control
Guideline-Based Recommendations
Diagnosis
Use cranial and spinal MRI to detect leptomeningeal involvement
Perform CSF sampling for cytology to confirm tumor cell presence
Consider biopsy in unclear diagnostic cases
Management
Local interventions such as neurosurgical resection of brain metastases and VP shunt or reservoir implantation for hydrocephalus
Radiotherapy including whole brain radiation therapy (WBRT) or craniospinal irradiation (CSI)
Systemic therapies including targeted therapy or receptor tyrosine kinase inhibitors after LMD diagnosis
Monitoring & Follow-up
Radiologic tumor assessment via MRI and CT staging to evaluate intracranial and extracranial disease burden
Classification of tumor response as complete response, partial response, stable disease, or progressive disease
Regular clinical and radiological follow-up to assess disease progression and treatment response
Risks
High morbidity associated with neurological deficits and hydrocephalus
Poor prognosis with late-stage metastatic CNS involvement
Increased risk of LMD relapse with longer overall survival due to improved systemic and local therapies
Patient & Prescribing Data
Patients with solid tumors and confirmed leptomeningeal disease, with or without brain metastases
Treatment includes multimodal approaches combining neurosurgery, radiotherapy, and systemic targeted therapies; prognostic factors influence treatment decisions and outcomes
Clinical Best Practices
Early and accurate diagnosis using combined MRI and CSF cytology to guide treatment
Stratify LMD patients by pattern (classic linear vs nodular) for prognostic assessment
Incorporate performance status and primary tumor control status in prognostic evaluation
Use multidisciplinary treatment approaches tailored to intracranial and extracranial disease burden
Apply standardized radiologic criteria (RANO, RECIST) for tumor response assessment
Consider molecular pathology data to guide targeted systemic therapies
by David Wasilewski, Chiara Eitner, Rober Ates, Selin Murad, Zoe Shaked, Julia Alexandra Steinle, Andreas Wetzel-Yalelis, Tarik Alp Sargut, Judith Rösler, Majd Abdulhamid Samman, Peter Truckenmüller, Robert Mertens, Daniel Kroneberg, Alexander Kowski, Helena Radbruch, David Capper, Felix Ehret, Siyer Roohani, Nikolaj Frost, Jawed Nawabi, Julia Onken, Maximilian Schlaak, Jens-Uwe Blohmer, Uwe Pelzer, Ulrich Keller, Jalid Sehouli, Peter Vajkoczy, Ulrich Keilholz, Martin Misch
